Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial

Author： Bernsdorf Mogens  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.126, Iss.2, 2011-04, pp. : 463-470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

By Massarweh Suleiman  

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 819-827

Springer Publishing Company

Access to resources Recommend Favorite

Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer

By Bernsdorf Mogens   Balslev Eva   Lykkesfeldt Anne   Kroman Niels   Harder Eva   Maase Hans   Jakobsen Erik   Grabau Dorthe   Ejlertsen Bent  

Breast Cancer Research and Treatment, Vol. 128, Iss. 1, 2011-07 ,pp. : 165-170

Springer Publishing Company

Access to resources Recommend Favorite

Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial

By Yoshikawa Takaki   Tanabe Kazuaki   Nishikawa Kazuhiro   Ito Yuichi   Matsui Takanori   Kimura Yutaka   Hirabayashi Naoki   Mikata Shoki   Iwahashi Makoto   Fukushima Ryoji   Takiguchi Nobuhiro   Miyashiro Isao   Morita Satoshi   Miyashita Yumi   Tsuburaya Aakira   Sakamoto Junichi  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 213-219

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

By Ramaswamy Bhuvaneswari   Povoski Steven   Rhoades Chris   Allen Joan   Hauger Marsha   Young Donn   Burak William   Farrar William   Yee Lisa   Kendra Kari   Somasundaram Sivagurunathan   Orlowski Robert   Shapiro Charles  

Breast Cancer Research and Treatment, Vol. 93, Iss. 1, 2005-09 ,pp. : 67-74

Springer Publishing Company

Access to resources Recommend Favorite

Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis

By            

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2825-2832

Spandidos Publications

Access to resources Recommend Favorite